0001179110-21-001129.txt : 20210202 0001179110-21-001129.hdr.sgml : 20210202 20210202202742 ACCESSION NUMBER: 0001179110-21-001129 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210129 FILED AS OF DATE: 20210202 DATE AS OF CHANGE: 20210202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Keson-Brookes Maiken CENTRAL INDEX KEY: 0001693805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38586 FILM NUMBER: 21583755 MAIL ADDRESS: STREET 1: 35 OAK HILL ROAD CITY: FAYVILLE STATE: MA ZIP: 01745 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rubius Therapeutics, Inc. CENTRAL INDEX KEY: 0001709401 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042688109 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-679-9600 MAIL ADDRESS: STREET 1: 399 BINNEY STREET, SUITE 300 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml FORM 4 - X0306 4 2021-01-29 0 0001709401 Rubius Therapeutics, Inc. RUBY 0001693805 Keson-Brookes Maiken C/O RUBIUS THERAPEUTICS, INC. 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 0 1 0 0 CLO & Corp. Secretary Stock Option (Right to Buy) 11.97 2021-01-29 4 A 0 142500 0 A 2031-01-28 Common Stock 142500 142500 D Restricted Stock Units 2021-01-29 4 A 0 32300 0 A Common Stock 32300 32300 D 25% of this option shall vest on January 29, 2022, then in 12 equal quarterly installments thereafter. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares underlying the restricted stock units will vest in four equal annual installments beginning on January 29, 2022. /s/ Joanne M. Protano, Attorney-in-Fact 2021-02-02